Patients had to have resolution of all ipilimumab-related adverse events to grade @-@ and prednisone @ mg/day or less for at least @ weeks , an Eastern Cooperative Oncology Group ( ECOG ) performance status of @ or @ , and at least one measurable lesion to be eligible .